Amit Z, Sutherland E A, Gill K, Ogren S O
Neurosci Biobehav Rev. 1984 Spring;8(1):35-54. doi: 10.1016/0149-7634(84)90019-8.
This review evaluates the literature and describes an extensive series of experiments which examined the effects of zimeldine , its metabolite norzimeldine and other serotonin and norepinephrine reuptake inhibitors on voluntary ethanol consumption in rats. The results of these experiments indicate that drugs which specifically inhibit serotonin reuptake are capable of decreasing voluntary ethanol consumption. The behavioral mechanism through which these drugs exert their effects seems to be extinction of the primary reinforcing properties of alcohol. These effects seem to be partially attenuated both by drugs which modulate the norepinephrine system as well as by the serotonin postsynaptic receptor blocker methergoline. The data presented in this review are discussed in terms of the involvement of the serotonin and norepinephrine systems in the mechanism of action of these drugs. In addition, several alternative hypotheses concerning the nature of the phenomenon are offered. Finally, the implications of these data for the possible development of a treatment procedure for problem drinkers is discussed.
本综述评估了相关文献,并描述了一系列广泛的实验,这些实验研究了齐美利定、其代谢产物去甲齐美利定以及其他血清素和去甲肾上腺素再摄取抑制剂对大鼠自愿乙醇摄入量的影响。这些实验结果表明,特异性抑制血清素再摄取的药物能够减少自愿乙醇摄入量。这些药物发挥作用的行为机制似乎是消除酒精的主要强化特性。这些作用似乎会被调节去甲肾上腺素系统的药物以及血清素突触后受体阻滞剂麦角新碱部分减弱。本综述中呈现的数据从血清素和去甲肾上腺素系统在这些药物作用机制中的参与情况进行了讨论。此外,还提出了关于该现象本质的几种替代假说。最后,讨论了这些数据对于可能开发问题饮酒者治疗程序的意义。